96 related articles for article (PubMed ID: 4855829)
1. Plasma half-life of phenylbutazone in patients with impaired liver function.
Hvidberg EF; Andreasen PB; Ranek L
Clin Pharmacol Ther; 1974 Feb; 15(2):171-7. PubMed ID: 4855829
[No Abstract] [Full Text] [Related]
2. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
Pond SM; Birkett DJ; Wade DN
Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
[TBL] [Abstract][Full Text] [Related]
4. Individual differences in the plasma half-lives of lipid soluble drugs in man.
Davies DS; Thorgeirsson SS
Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():181-90. PubMed ID: 5316400
[No Abstract] [Full Text] [Related]
5. Oxyphenbutazone and phenylbutazone determination in plasma and urine by GLC.
Bruce RB; Maynard WR; Dunning LK
J Pharm Sci; 1974 Mar; 63(3):446-8. PubMed ID: 4820382
[No Abstract] [Full Text] [Related]
6. Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone.
Jähnchen E; Levy G
Proc Soc Exp Biol Med; 1972 Dec; 141(3):963-5. PubMed ID: 4645785
[No Abstract] [Full Text] [Related]
7. Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
Pound NJ; Sears RW
J Pharm Sci; 1975 Feb; 64(2):284-7. PubMed ID: 1127584
[TBL] [Abstract][Full Text] [Related]
8. GLC determination of plasma concentration of phenylbutazone and its metabolite oxyphenbutazone.
Midha KK; McGilveray IJ; Charette C
J Pharm Sci; 1974 Aug; 63(8):1234-9. PubMed ID: 4852201
[No Abstract] [Full Text] [Related]
9. Phenylbutazone overdosage: abnormal metabolism associated with hepatic and renal damage.
Prescott LF; Critchley JA; Balali-Mood M
Br Med J; 1980 Oct; 281(6248):1106-7. PubMed ID: 7427601
[No Abstract] [Full Text] [Related]
10. [Reduction of plasma concentrations of phenylbutazone and oxyphenbutazone in smokers].
Ollagnier M; Queneau P; Latour JF; Brazier JL; Decousus H; Faucon G
Therapie; 1982; 37(5):549-56. PubMed ID: 7179323
[No Abstract] [Full Text] [Related]
11. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
Spahn H; Mutschler E
Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
[TBL] [Abstract][Full Text] [Related]
12. Separation of furosemide, phenylbutazone and oxyphenbutazone in plasma by direct injection onto internal surface reversed-phase columns with systematic optimization of selectivity.
Pinkerton TC; Perry JA; Rateike JD
J Chromatogr; 1986 Oct; 367(2):412-8. PubMed ID: 3782354
[No Abstract] [Full Text] [Related]
13. Studies of the interaction of phenylbutazone, oxyphenbutazone and methandrostenolone in man.
Hvidberg EF; Dayton PG; Read JM; Wilson CH
Proc Soc Exp Biol Med; 1968 Nov; 129(2):438-43. PubMed ID: 5696765
[No Abstract] [Full Text] [Related]
14. Disposition and oxidative metabolism of phenylbutazone in man.
Aarbakke J; Bakke OM; Milde EJ; Davies DS
Eur J Clin Pharmacol; 1977; 11(5):359-66. PubMed ID: 880975
[No Abstract] [Full Text] [Related]
15. Influence of dietary portein on the disposition and metabolism of phenylbutazone in rats.
Varma DR
Can J Physiol Pharmacol; 1980 Mar; 58(3):231-6. PubMed ID: 7378926
[TBL] [Abstract][Full Text] [Related]
16. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
Tobin T; Blake JW; Valentine R
Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
[TBL] [Abstract][Full Text] [Related]
17. A phenylbutazone dose-finding study in rheumatoid arthritis.
Bird HA; Leatham PA; Lowe JR; Downie WW; Fowler PD; Wright V
Eur J Clin Pharmacol; 1983; 24(6):773-6. PubMed ID: 6884415
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
[TBL] [Abstract][Full Text] [Related]
19. [Influence of tobacco on the serum levels and pharmacokinetics of phenylbutazone and oxyphenbutazone].
Queneau P; Ollagnier M; Decousus H; Perpoint B; Brazier JL; Faucon L
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):293-7. PubMed ID: 6879097
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of phenylbutazone in neonatal foals.
Wilcke JR; Crisman MV; Sams RA; Gerken DF
Am J Vet Res; 1993 Dec; 54(12):2064-7. PubMed ID: 8116939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
